GGrantIndex
← Search

MULTICENTER STUDY OF HYDROXYUREA IN SICKLE CELL DISEASE

$0M01FY2000RRNIH

University Of California San Francisco, San Francisco CA

Investigators

Linked publications & trials

Abstract

The objectives of the Multicenter Study of Hydroxyurea in sickle cell disease will be to determine whether there are any long-term adverse effects of treatment of sickle cell anemia with hydroxyurea. Untoward effects of hydroxyurea could be reflected in mortality, adverse reproductive outcomes, the development of additional serious medical complications, impairment or failure of specific organs or systems (i.e. kidney, liver, central nervous system).

View original record on NIH RePORTER →